|
|
||||||||
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Correspondence: For reprints contact: Reginald Greene, Massachusetts General Hospital, Boston, Massachusetts 02114.
ABSTRACT
The technique and potential clinical advantages of airway closure and pulmonary ventilation studies with high-specific-activity 13N-labeled molecular nitrogen are presented. External detection of 13N is described in ventilation studies, and the simultaneous monitoring of lung volume changes and of expired 13N boluses are described in airway closure measurements. The application of these studies may be of particular significance in the early detection of obstructive lung disease and pathophysiological mechanisms involving the lung in cardiorespiratory disorders.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |